Inventor · disambiguated record
Peter Raymond Flatt
Also filed as: FLATT PETER · FLATT PETER R · FLATT PETER RAYMOND
12 granted patents·13 pending applications·139 citations·filing 1993–2020
89Inventor score
Top patents by PatentIndex Score
25 records- 0194US7326688B2Analogs of gastric inhibitory polypeptide and their use of treatment for diabetesUUTECH LTD·Filed 2005·Granted Feb 5, 2008·50 cites·135 claims
- 0290US6921748B1Analogs of gastric inhibitory polypeptide and their use for treatment of diabetesUUTECH LTD·Filed 2000·Granted Jul 26, 2005·27 cites·28 claims
- 0389US7875587B2Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesityUUTECH LTD·Filed 2007·Granted Jan 25, 2011·20 cites·12 claims
- 0488US7666838B2Analogs of gastric inhibitory polypeptide and their use for treatment of diabetesUUTECH LTD·Filed 2007·Granted Feb 23, 2010·12 cites·25 claims
- 0581US5430188AProcess for the preparation of 2-alkyl-6-methyl-N-(1'-methoxy-2'-propyl)-aniline and a process for the preparation of their chloracetanilidesCIBA GEIGY CORP·Filed 1993·Granted Jul 4, 1995·23 cites·28 claims
- 0672US7402663B2Modified peptideUNIV ULSTER·Filed 2002·Granted Jul 22, 2008·7 cites·4 claims
- 0765US2008009603A1Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesityUUTECH LTD·Filed 2007·Application pending·0 cites
- 0858US11541019B2Compositions for use in the treatment of diabetesUNIV ULSTER·Filed 2020·Granted Jan 3, 2023·0 cites·10 claims
- 0957US2010129934A1Glycated Insulin as a Biomarker for Diagnosis and Monitoring of DiabetesMCKILLOP AINE M·Filed 2009·Application pending·0 cites
- 1053US2009170762A1Treatment of Diabetes Related ObesityUUTECH LTD·Filed 2006·Application pending·0 cites
- 1152US2005272652A1Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesityGAULT VICTOR A·Filed 2005·Application pending·0 cites
- 1251US9060991B2Use of GLP-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmissionFLATT PETER RAYMOND·Filed 2008·Granted Jun 23, 2015·0 cites·12 claims
- 1350US12508295B2Piscine-derived PYY peptides for use in treating a metabolic disorderUNIV ULSTER·Filed 2019·Granted Dec 30, 2025·0 cites·8 claims
- 1450US2008058269A1Insulin Releasing PeptidesUNVERSITY OF ULSTER·Filed 2004·Application pending·0 cites
- 1549US2015197550A1Therapeutic Uses of Dogfish Glucagon and Analogues ThereofUNIV ULSTER·Filed 2013·Application pending·0 cites
- 1649US2010267628A1Analogs of Gastric Inhibitory Polypeptide and Their Use for Treatment of DiabetesO'HARTE FINBARR PAUL MARY·Filed 2010·Application pending·0 cites
- 1747US2006121532A1Glycated insulin as a biomarker for diagnosis and monitoring of diabetesUUTECH LTD·Filed 2003·Application pending·0 cites
- 1844US2018228742A1Compositions for use in the treatment of diabetesUNIV ULSTER·Filed 2016·Application pending·0 cites
- 1943US2004005702A1Insulin producing cell-lineFiled 2001·Application pending·0 cites
- 2043US2009281032A1Modified CCK peptidesFLATT PETER RAYMOND·Filed 2008·Application pending·0 cites
- 2142US2009286722A1Analogs of Gastric Inhibitory Polypeptide as a Treatment for Age Related Decreased Pancreatic Beta Cell FunctionUTECH LTD·Filed 2006·Application pending·0 cites
- 2241US9062125B2Use of GIP for the treatment of disorders associated with dysfunctional synaptic transmissionFLATT PETER RAYMOND·Filed 2008·Granted Jun 23, 2015·0 cites·5 claims
- 2338US2015025002A1Peptides and peptide derivatives based on xeninUNIV ULSTER·Filed 2013·Application pending·0 cites
- 2435US10118954B2Apelin analoguesUNIV ULSTER·Filed 2015·Granted Nov 6, 2018·0 cites·14 claims
- 2523US10202427B2Esculentin-2CHa peptide and analogues thereofUNIV ULSTER·Filed 2015·Granted Feb 12, 2019·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →